 Connection
Raphael Nemenoff to Immunoblotting
This is a "connection" page, showing publications Raphael Nemenoff has written about Immunoblotting.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.069 |
|
|
|
-
Wick M, Hurteau G, Dessev C, Chan D, Geraci MW, Winn RA, Heasley LE, Nemenoff RA. Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth. Mol Pharmacol. 2002 Nov; 62(5):1207-14.
Score: 0.047
-
Meyer AM, Dwyer-Nield LD, Hurteau GJ, Keith RL, O'Leary E, You M, Bonventre JV, Nemenoff RA, Malkinson AM. Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis. 2004 Aug; 25(8):1517-24.
Score: 0.013
-
Niederberger M, Ginès P, Martin PY, St John J, Woytaszek P, Xu L, Tsai P, Nemenoff RA, Schrier RW. Increased renal and vascular cytosolic phospholipase A2 activity in rats with cirrhosis and ascites. Hepatology. 1998 Jan; 27(1):42-7.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|